http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#Head http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#assertion http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#provenance http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#pubinfo http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#assertion http://purl.obolibrary.org/obo/DOID_10456 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_10456 http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00833 http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association http://www.w3.org/2000/01/rdf-schema#label cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms otitis media streptococcus pneumoniae haemophilus influenzae streptococcus pyogenes note b haemophilus influenzae in vitro lower respiratory tract infections streptococcus pneumoniae haemophilus influenzae streptococcus pyogenes note b haemophilus influenzae in vitro pharyngitis and tonsillitis streptococcus pyogenes note urinary tract infections escherichia coli proteus mirabilis klebsiella skin and skin structure infections staphylococcus aureus streptococcus pyogenes appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor to reduce the development of drug resistant bacteria and maintain the effectiveness of cefaclor for oral suspension and other antibacterial drugs cefaclor for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00833 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#provenance http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#pubinfo http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#sig http://purl.org/nanopub/x/hasSignature e2vlEHWjCWhhij+qyvNtmA0CjEWguKeGXOAJNtnzHkLQFiw7tRoKS2JaEkWQ+VcOhJFxPSwnGkjR1iWIiIGvBe3qVq4NvyrwjOnVqemSN+7S27ayqGfYf+aR8fyxaCxlDl7HZiEbAu78LQQciRFv59dSDvVHontAwx85yKDJfh4= http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI http://purl.org/dc/terms/created 2021-06-13T12:09:47.600+02:00 http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs